00:00A pilot trial suggests support may limit early weight gain after GLP-1 drugs are stopped.
00:05GLP-1 drugs are obesity medicines, and 39 adults entered this tough study.
00:10Researchers published the pilot randomized trial in Obesity Science and Practice.
00:15They assigned adults to usual care, a digital wellness application, or medically tailored meals.
00:21And they followed them for four months after GLP-1 cessation.
00:24In the control group, weight rose an estimated 10.75% body weight.
00:30But it rose 3.60% with the wellness application and 3.58% with meals.
00:36Surveys found diet quality, perceived health, adherence, and satisfaction did not differ significantly.
00:44Even so, some estimates hinted at trends favoring the wellness application.
00:49Kelsiana Hollis Hansen, the corresponding author at Tufts, said people invest significant time and effort.
00:55She added,
00:56We need evidence-based strategies to support them.
00:58So the question was, whether that support could help hold on to the gains.
01:03Disclosure, this video contains stock footage and content created or enhanced using AI-assisted tools.
01:08L
